Literature DB >> 10335777

Non-alcoholic steatohepatitis: another disease of affluence.

O James1, C Day.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10335777     DOI： 10.1016/S0140-6736(99)00163-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  43 in total

1.  Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey.

Authors:  Lei Shen; Jian-Gao Fan; Yan Shao; Min-De Zeng; Jun-Rong Wang; Guo-Hao Luo; Ji-Qiang Li; Si-Yao Chen
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

2.  Non-Alcoholic Steatohepatitis (NASH).

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-12

Review 3.  [End-organ damage in hyperlipidemias].

Authors:  M Faust; W Krone
Journal:  Internist (Berl)       Date:  2003-07       Impact factor: 0.743

Review 4.  Correction of dysfunctional fatty acid metabolism using peroxisome proliferator activated receptor gamma agonists.

Authors:  Nicholas D Oakes; Bengt Ljung; Germán Camejo
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

5.  Effects of ursodeoxycholic acid and/or low-calorie diet on steatohepatitis in rats with obesity and hyperlipidemia.

Authors:  Jian-Gao Fan; Lan Zhong; Li-Yan Tia; Zheng-Jie Xu; Min-Sheng Li; Guo-Liang Wang
Journal:  World J Gastroenterol       Date:  2005-04-21       Impact factor: 5.742

Review 6.  The emerging role of mast cells in liver disease.

Authors:  Veronica Jarido; Lindsey Kennedy; Laura Hargrove; Jennifer Demieville; Joanne Thomson; Kristen Stephenson; Heather Francis
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-05-04       Impact factor: 4.052

Review 7.  Non-alcoholic fatty liver disease: a diabetologist's perspective.

Authors:  Joseph M Pappachan; Farrah A Antonio; Mahamood Edavalath; Arjun Mukherjee
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

8.  Multiple short bouts of exercise over 12-h period reduce glucose excursions more than an energy-matched single bout of exercise.

Authors:  Michael Holmstrup; Timothy Fairchild; Stefan Keslacy; Ruth Weinstock; Jill Kanaley
Journal:  Metabolism       Date:  2013-12-14       Impact factor: 8.694

9.  Curcumin eliminates oxidized LDL roles in activating hepatic stellate cells by suppressing gene expression of lectin-like oxidized LDL receptor-1.

Authors:  Qiaohua Kang; Anping Chen
Journal:  Lab Invest       Date:  2009-09-07       Impact factor: 5.662

Review 10.  Inflammatory mediators of hepatic steatosis.

Authors:  Elizabeth Hijona; Lander Hijona; Juan I Arenas; Luis Bujanda
Journal:  Mediators Inflamm       Date:  2010-03-16       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.